P897: UPDATED RESULTS FROM THE ONGOING PHASE 1 STUDY OF ELRANATAMAB, A BCMA TARGETED T‐CELL REDIRECTING IMMUNOTHERAPY, FOR PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA von Dalovisio, A., Bahlis, N., Raje, N., Costello, C., Dholaria, B., Solh, M., Levy, M., Tomasson, M., Dube, H., Damore, M., Jiang, S., Basu, C., Skoura, A., Chan, E., Trudel, S., Jakubowiak, A., Chu, M., Gasparetto, C., Sebag, M., Lesokhin, A.

Volltext

EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135), A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA von Solh, M, Bahlis, NJ, Raje, NS, Costello, CL, Dholaria, B, Levy, MY, Tomasson, MH, Dube, H, Damore, MA, Lon, HK, Basu, C, Skoura, A, Chan, EM, Trudel, S, Jakubowiak, A, Chu, MP, Gasparetto, C, Dalovisio, A, Sebag, M, Lesokhin, AM

Volltext

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and th... von Rybak, Michael J., Lomaestro, Ben M., Rotscahfer, John C., Moellering, Robert C., Craig, Willam A., Billeter, Marianne, Dalovisio, Joseph R., Levine, Donald P.

Volltext

Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy von Tice, Alan D., Rehm, Susan J., Dalovisio, Joseph R., Bradley, John S., Martinelli, Lawrence P., Graham, Donald R., Gainer, R. Brooks, Kunkel, Mark J., Yancey, Robert W., Williams, David N.

Volltext

Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic von Saravolatz, Louis D., Billeter, Marianne, Zervos, Marcus J., Chen, Anne Y., Dalovisio, Joseph R., Kurukularatne, Changa

Volltext

Therapeutic Monitoring of Vancomycin in Adults: Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of Amer... von RYBAK, Michael J, LOMAESTRO, Ben M, ROTSCHAFER, John C, MOELLERING, Robert C, CRAIG, William A, BILLETER, Marianne, DALOVISIO, Joseph R, LEVINE, Donald P

Volltext

Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial von Bahlis, Nizar J., Costello, Caitlin L., Raje, Noopur S., Levy, Moshe Y., Dholaria, Bhagirathbhai, Solh, Melhem, Tomasson, Michael H., Damore, Michael A., Jiang, Sibo, Basu, Cynthia, Skoura, Athanasia, Chan, Edward M., Trudel, Suzanne, Jakubowiak, Andrzej, Gasparetto, Cristina, Chu, Michael P., Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander M.

Volltext

Older Patients With Acute Myeloid Leukemia: Treatment Challenges and Future Directions von Finn, Laura, Dalovisio, Andrew, Foran, James

Volltext

A Single Institution Experience of Treating Patients with High Dose Methotrexate for Primary CNS Lymphoma and with Secondary CNS Involvement von Lalani, Tanya L, Staton, Ashley D., Dalovisio, Andrew P., Finn, Laura E., Badari, Ambuga, Davis, Carter Thomas

Volltext

Molecular features and outcomes for patients receiving elranatamab for relapsed or refractory multiple myeloma in MagnetisMM-1 von Tomasson, Michael H., Bahlis, Nizar J., Costello, Caitlin, Raje, Noopur S., Levy, Moshe Y., Dholaria, Bhagirathbhai R., Solh, Melhem M., Damore, Michael A., Jiang, Sibo, Xie, Tao, Basu, Cynthia, Skoura, Athanasia, Chan, Edward Michael, Trudel, Suzanne, Jakubowiak, Andrzej J., Gasparetto, Cristina, Chu, Michael, Dalovisio, Andrew Peter, Sebag, Michael, Lesokhin, Alexander M.

Volltext

Financial Impact of a Home Intravenous Antibiotic Program on a Medicare Managed Care Program von Dalovisio, Joseph R., Juneau, Jan, Baumgarten, Katherine, Kateiva, Joan

Volltext

IDSA: Infancy to Adulthood in Four Decades von Dalovisio, Joseph R.

Volltext

Elranatamab, a BCMA Targeted T-Cell Engaging Bispecific Antibody, Induces Durable Clinical and Molecular Responses for Patients with Relapsed or Refractory Multiple Myeloma von Raje, Noopur, Bahlis, Nizar Jacques, Costello, Caitlin, Dholaria, Bhagirathbhai, Solh, Melhem, Levy, Moshe Yair, Tomasson, Michael H, Damore, Michael A., Jiang, Sibo, Basu, Cynthia, Skoura, Athanasia, Chan, Edward M, Trudel, Suzanne, Jakubowiak, Andrzej, Chu, Michael P, Gasparetto, Cristina J., Dalovisio, Andrew P., Sebag, Michael, Lesokhin, Alexander M

Volltext

Elranatamab, a BCMA-targeted T-cell redirecting immunotherapy, for patients with relapsed or refractory multiple myeloma: Updated results from MagnetisMM-1 von Jakubowiak, Andrzej J., Bahlis, Nizar J., Raje, Noopur S., Costello, Caitlin, Dholaria, Bhagirathbhai R., Solh, Melhem M., Levy, Moshe Y., Tomasson, Michael H, Dube, Harman, Damore, Michael A., Jiang, Sibo, Basu, Cynthia, Skoura, Athanasia, Chan, Edward Michael, Trudel, Suzanne, Chu, Michael P, Gasparetto, Cristina J., Dalovisio, Andrew Peter, Sebag, Michael, Lesokhin, Alexander M.

Volltext

Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Acute Myeloid Leukemia (AML): Results of Newly Diagnosed High-R... von Zeidner, Joshua F., Lee, Daniel J., Fine, Gil, Wang, Eunice S., Bhatt, Vijaya R., Dalovisio, Andrew, Montesinos, Pau, Kolibaba, Kathryn S., Anthony, Stephen P., Bearss, David J., Smith, B. Douglas

Volltext

Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA) Targeted CD3-Engaging Bispecific Molecule, for Patients with Relapsed or Refractory Multiple Myeloma: Results from Mag... von Sebag, Michael, Raje, Noopur S., Bahlis, Nizar J., Costello, Caitlin, Dholaria, Bhagirathbhai, Solh, Melhem, Levy, Moshe Y., Tomasson, Michael H., Dube, Harman, Damore, Michael A., Lon, Hoi Ken, Basu, Cynthia, Skoura, Athanasia, Chan, Edward, Trudel, Suzanne, Jakubowiak, Andrzej, Chu, Michael P., Gasparetto, Cristina, Dalovisio, Andrew P., Lesokhin, Alexander

Volltext

Midostaurin in Adults with Newly Diagnosed FLT3-Mutation-Positive Acute Myeloid Leukemia Eligible for Standard Chemotherapy: Update from the Radius-X Midostaurin Expanded Access Pr... von Perl, Alexander E., Sweet, Kendra L., Roboz, Gail J., Strickland, Stephen A., Litzow, Mark R., Bonifacio, Gaetano J, Haines, Kelly, Barbera, Alysha, Purkayastha, Das, Dalovisio, Andrew

Volltext

Efficacy and safety of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MM) von Bahlis, Nizar J., Raje, Noopur S., Costello, Caitlin, Dholaria, Bhagirathbhai R., Solh, Melhem M., Levy, Moshe Y., Tomasson, Michael H, Dube, Harman, Liu, Feng, Liao, Kai Hsin, Basu, Cynthia, Skoura, Athanasia, Chan, Edward Michael, Trudel, Suzanne, Jakubowiak, Andrzej J., Chu, Michael P, Gasparetto, Cristina, Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander M.

Volltext

A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia von Zeidner, Joshua F., Lin, Tara L., Vigil, Carlos E., Fine, Gil, Yair Levy, M., Nazha, Aziz, Esteve, Jordi, Lee, Daniel J., Yee, Karen, Dalovisio, Andrew, Wang, Eunice S., Bergua Burgues, Juan M., Schriber, Jeffrey, Litzow, Mark R., Frankfurt, Olga, Castillo, Teresa Bernal Del, Bhatt, Vijaya Raj, Bhatnagar, Bhavana, Mehta, Priyanka, Dillon, Richard, Vicente, Maria Vidriales, Anthony, Stephen, Bearss, David, Montesinos, Pau, Douglas Smith, B.

Volltext

Preliminary Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Subcutaneously (SC) Administered PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in... von Lesokhin, Alexander M., Levy, Moshe Y., Dalovisio, Andrew P., Bahlis, Nizar J., Solh, Melhem, Sebag, Michael, Jakubowiak, Andrzej, Jethava, Yogesh S., Costello, Caitlin L., Chu, Michael P., Savona, Michael R., Gasparetto, Cristina, Trudel, Suzanne, Chou, Jeffrey, Udata, Chandrasekhar, Basu, Cynthia, Krupka, Heike I., Raje, Noopur S.

Volltext